ArticleBMC ophthalmology2025

One-year clinical outcomes of four-dose induction versus immediate treat-and-extend faricimab regimens in pretreated neovascular age-related macular degeneration.

Moreno Menghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.